John Mckune - Net Worth and Insider Trading
John Mckune Net Worth
The estimated net worth of John Mckune is at least $389,403 dollars as of 2024-11-29. John Mckune is the INTERIM CFO of Pulmonx Corp and owns about 61,810 shares of Pulmonx Corp (LUNG) stock worth over $389,403. Details can be seen in John Mckune's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Mckune has not made any transactions after 2024-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Mckune
John Mckune Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Mckune owns 2 companies in total, including KalVista Pharmaceuticals Inc (KALV) , and Pulmonx Corp (LUNG) .
Click here to see the complete history of John Mckune’s form 4 insider trades.
Insider Ownership Summary of John Mckune
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2015-08-05 | See Remarks |
| LUNG | Pulmonx Corp | 2024-03-01 | Interim CFO |
John Mckune Latest Holdings Summary
John Mckune currently owns a total of 1 stock. John Mckune owns 61,810 shares of Pulmonx Corp (LUNG) as of March 1, 2024, with a value of $389,403.
Latest Holdings of John Mckune
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LUNG | Pulmonx Corp | 2024-03-01 | 61,810 | 6.30 | 389,403 |
Holding Weightings of John Mckune
John Mckune Form 4 Trading Tracker
According to the SEC Form 4 filings, John Mckune has made a total of 2 transactions in Pulmonx Corp (LUNG) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Pulmonx Corp is the sale of 1,078 shares on March 1, 2024, which brought John Mckune around $9,767.
Insider Trading History of John Mckune
- 1
John Mckune Trading Performance
John Mckune Ownership Network
John Mckune Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
John Mckune is the See Remarks of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Medical Officer Paul K. Audhya , Chief Development Officer Christopher Yea , and CFO and Secretary Benjamin L Palleiko .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, John Mckune made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 155,123 shares made by Benjamin L Palleiko , and a net sale of 95,977 shares made by Christopher Yea .
In summary, during the past 3 months, insiders sold 41,171 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 41,171 shares. During the past 18 months, 600,355 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 650,662 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
John Mckune Mailing Address
Above is the net worth, insider trading, and ownership report for John Mckune. You might contact John Mckune via mailing address: 46668 Crawford Ct., Fremont Ca 94539.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
